China SXT Pharmaceuticals... (SXTC)
NASDAQ: SXTC
· Real-Time Price · USD
1.62
0.04 (2.53%)
At close: Aug 15, 2025, 3:02 PM
China SXT Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 414.75K | 414.75K | 494.46K | 494.46K | 939.58K | 469.79K | 763.39K | 381.7K | 1.21M | 604.14K | -11.5M | 787.3K | 1.03M | 513.84K | -9.33M | 458.54K | 1.93M | 1.93M |
Cost of Revenue | 347.37K | 347.37K | 361.64K | 361.64K | 753.99K | 325.62K | 426.8K | 213.4K | 1.12M | 559.3K | 4.03M | 323.46K | 703.72K | 351.86K | 3.44M | 449.23K | 519.78K | 519.78K |
Gross Profit | 67.38K | 67.38K | 132.81K | 132.81K | 185.59K | 144.17K | 336.59K | 168.29K | 89.68K | 44.84K | -15.53M | 463.84K | 323.96K | 161.98K | -12.77M | 9.31K | 1.41M | 1.41M |
Operating Income | -319.13K | -319.13K | 3.42M | 3.42M | -9.35M | -4.67M | -4.46M | -2.05M | -1.15M | -575.22K | 1.28M | -1.15M | -2.89M | -1.45M | 2.42M | -1.68M | 581.9K | 581.9K |
Interest Income | n/a | n/a | n/a | n/a | n/a | 168.26K | 46.24K | 46.24K | 192.14K | 192.14K | n/a | 18.38K | 34.00 | 35.00 | n/a | 332.18K | n/a | 221.04K |
Pretax Income | -401.28K | -401.28K | 3.3M | 3.3M | -9.7M | -4.85M | -4.44M | -2.22M | -1.49M | -747.3K | 2.38M | -1.32M | -2.77M | -1.38M | 4.85M | -2.28M | 808.14K | 808.14K |
Net Income | -401.28K | -401.28K | 3.3M | 3.3M | -9.7M | -4.85M | -4.44M | -2.22M | -1.49M | -747.3K | 2.32M | -1.32M | -3.09M | -1.55M | 5.31M | -2.06M | 690.63K | 690.63K |
Selling & General & Admin | 386.51K | 386.51K | 3.5M | 3.5M | 9.53M | 4.82M | 4.79M | 2.22M | 1.24M | 620.07K | -8.44M | 1.61M | 3.22M | 1.61M | -11.17M | 1.69M | 519.78K | 828.56K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | -6.78M | -6.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 386.51K | 386.51K | -3.28M | -3.28M | 9.53M | 4.82M | 4.79M | 2.34M | 1.24M | 600K | -8.44M | 1.77M | 3.22M | 1.55M | -11.17M | 1.96M | 519.78K | 381.29K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 92.49K | n/a | 384.29K | n/a | 3.56M | n/a | n/a | n/a | 1.98M | n/a | n/a | n/a |
Selling & Marketing Expenses | 25.31K | 25.31K | 128.31K | 128.31K | 88.47K | 88.47K | 57.64K | 57.64K | 136.08K | 136.08K | -924.54K | 263.86K | 198.41K | 198.41K | -1.59M | 441.39K | -308.78K | 352.28K |
Cost & Expenses | 733.88K | 733.88K | -2.92M | -2.92M | 10.29M | 5.15M | 5.22M | 2.56M | 2.36M | 1.16M | -4.41M | 2.09M | 3.92M | 1.9M | -7.73M | 2.4M | 1.04M | 901.07K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 3.00 | n/a | 4.00 | n/a | -596.16K | 1.18K | 325.78K | 162.89K | -75.33K | 213.85K | 117.51K | 117.51K |
Shares Outstanding (Basic) | 403.92K | 403.92K | 1.23M | 867.42K | 501.47K | 501.47K | 431.63K | 431.63K | 102.32K | 102.32K | 52.08K | 52.08K | 31.1K | 31.1K | 28.78K | 28.78K | 28.78K | 28.78K |
Shares Outstanding (Diluted) | 403.92K | 403.92K | 1.23M | 867.42K | 501.47K | 501.47K | 431.63K | 431.63K | 102.32K | 102.32K | 52.08K | 52.08K | 31.1K | 31.1K | 28.78K | 28.78K | 28.78K | 28.78K |
EPS (Basic) | -0.99 | -0.99 | 2.67 | 2.67 | -9.67 | -9.67 | -5.14 | -5.14 | -7.3 | -7.3 | -25.39 | -25.39 | -49.71 | -49.71 | -71.73 | -71.73 | 24.00 | 24.00 |
EPS (Diluted) | -0.99 | -0.99 | 2.67 | 3.80 | -9.67 | -9.67 | -5.14 | -5.14 | -7.3 | -7.3 | -25.39 | -25.39 | -49.71 | -49.71 | -71.73 | -71.73 | 24.00 | 24.00 |
EBITDA | -284.86K | -284.86K | 3.68M | 3.68M | -4.62M | -4.62M | -1.98M | -1.98M | -520.24K | -520.24K | -1.08M | -1.08M | -1.35M | -1.35M | -1.6M | -1.6M | 658.23K | 673.37K |
EBIT | -319.13K | -319.13K | 3.63M | 3.63M | -4.67M | -4.67M | -2.05M | -2.05M | -575.22K | -575.22K | -1.15M | -1.15M | -1.45M | -1.45M | -1.68M | -1.68M | 581.9K | 581.9K |
Depreciation & Amortization | 34.27K | 34.27K | 50.25K | 50.25K | 102.75K | 51.38K | 140.2K | 70.1K | 109.97K | 54.98K | 134.01K | 67K | 186K | 93K | 162.49K | 81.24K | 182.93K | 91.46K |